Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
SRPT on Nasdaq
Shares outstanding
104,849,534
Price per share
$21.13
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
93,343,737
Total reported value
$2,008,639,594
% of total 13F portfolios
0%
Share change
+7,658,259
Value change
+$171,052,049
Number of holders
341
Price from insider filings
$21.13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $284,766,671 13,232,652 BlackRock, Inc. 31 Dec 2025
VANGUARD GROUP INC 11% $190,912,690 10,641,733 The Vanguard Group 29 Aug 2025
AQR CAPITAL MANAGEMENT LLC 7.7% $171,336,931 8,104,869 AQR Capital Management, LLC 31 Dec 2025
STATE STREET CORP 5.4% $102,225,558 5,304,907 STATE STREET CORPORATION 30 Sep 2025
D. E. SHAW & CO, L.P. 1.9% -64% $38,675,372 -$58,829,132 2,007,025 -60% D. E. Shaw & Co., L.P. 30 Sep 2025
Capital International Investors 0.5% -98% $9,523,733 -$152,120,639 524,146 -94% Capital International Investors 30 Jun 2025

As of 31 Dec 2025, 341 institutional investors reported holding 93,343,737 shares of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT). This represents 89% of the company’s total 104,849,534 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) together control 68% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 14% 14,283,253 +8.2% 0.01% $307,375,600
VANGUARD GROUP INC 11% 11,810,729 +9.2% 0% $254,166,887
AQR CAPITAL MANAGEMENT LLC 7.4% 7,796,535 +455% 0.09% $167,781,432
STATE STREET CORP 6.3% 6,599,441 +24% 0% $142,019,970
Erste Asset Management GmbH 2.6% 2,728,945 +1.6% 0.49% $58,726,896
TWO SIGMA INVESTMENTS, LP 2.3% 2,441,455 +14% 0.08% $52,540,112
Aberdeen Group plc 2.1% 2,251,593 +14% 0.08% $48,454,281
TWO SIGMA ADVISERS, LP 2% 2,071,334 +5.8% 0.09% $44,575,108
UBS Group AG 2% 2,058,701 +3.4% 0.01% $44,303,245
FIRST TRUST ADVISORS LP 1.9% 1,992,577 +2.7% 0.03% $42,880,264
MORGAN STANLEY 1.8% 1,912,635 -1.8% 0% $41,159,916
GEODE CAPITAL MANAGEMENT, LLC 1.8% 1,904,325 +11% 0% $40,990,106
BANK OF AMERICA CORP /DE/ 1.6% 1,694,590 +111% 0% $36,467,583
D. E. Shaw & Co., Inc. 1.5% 1,540,390 -23% 0.03% $33,149,193
FEDERATED HERMES, INC. 1.3% 1,313,313 +0.35% 0.05% $28,262,496
RENAISSANCE TECHNOLOGIES LLC 1.1% 1,159,578 -56% 0.04% $24,954,119
CITIGROUP INC 1.1% 1,146,175 +12% 0.02% $24,665,686
Connor, Clark & Lunn Investment Management Ltd. 1% 1,082,762 -38% 0.06% $23,301,038
MILLENNIUM MANAGEMENT LLC 0.95% 1,000,109 +252% 0.02% $21,522,346
T. Rowe Price Investment Management, Inc. 0.85% 892,065 -35% 0.01% $19,198,000
Voleon Capital Management LP 0.84% 879,953 +76% 0.41% $18,936,589
VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.84% 878,393 -33% 0.07% $18,903,017
683 Capital Management, LLC 0.77% 810,000 -18% 1.4% $17,431,200
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.73% 765,383 +26% 0% $16,471,042
JPMORGAN CHASE & CO 0.71% 743,988 +11% 0% $16,010,622

Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 93,343,737 $2,008,639,594 +$171,052,049 $21.52 341
2025 Q3 86,821,574 $1,674,984,415 +$93,432,524 $19.27 314
2025 Q2 82,768,888 $1,414,059,003 -$616,173,124 $17.10 354
2025 Q1 85,664,154 $5,483,381,207 -$371,527,547 $63.82 419
2024 Q4 87,843,903 $10,682,091,570 +$115,071,840 $121.59 459
2024 Q3 86,796,388 $10,834,992,283 -$451,898,219 $124.89 451
2024 Q2 88,782,224 $14,026,709,174 +$922,747,140 $158.00 479
2024 Q1 83,236,471 $10,771,794,424 +$210,287,311 $129.46 408
2023 Q4 81,574,475 $7,866,654,991 -$295,015,527 $96.43 386
2023 Q3 83,265,476 $10,092,124,857 +$213,088,130 $121.22 390
2023 Q2 81,723,093 $9,359,752,457 +$62,411,602 $114.52 399
2023 Q1 81,211,200 $11,191,507,838 +$325,102,660 $137.83 422
2022 Q4 78,931,000 $10,227,280,074 +$92,872,677 $129.58 405
2022 Q3 78,254,620 $8,650,122,111 +$568,958,858 $110.54 364
2022 Q2 73,313,897 $5,496,320,989 +$35,960,887 $74.96 312
2022 Q1 73,015,967 $5,705,221,328 +$56,363,206 $78.12 314
2021 Q4 71,894,248 $6,474,592,585 +$536,221,296 $90.05 326
2021 Q3 65,753,485 $6,079,879,477 +$130,063,243 $92.48 297
2021 Q2 64,801,548 $5,037,256,042 -$83,636,915 $77.74 315
2021 Q1 66,263,834 $4,936,320,529 -$714,137,111 $74.53 346
2020 Q4 70,628,202 $12,036,993,873 -$160,139,710 $170.49 435
2020 Q3 72,104,327 $10,123,672,605 -$335,637,260 $140.43 393
2020 Q2 73,863,151 $11,844,121,308 +$150,679,056 $160.34 397
2020 Q1 73,412,115 $7,179,418,082 -$46,251,906 $97.82 346
2019 Q4 73,511,794 $9,484,309,752 +$56,244,489 $129.04 379
2019 Q3 73,245,840 $5,516,516,594 -$252,303,319 $75.32 329
2019 Q2 71,710,913 $10,889,813,246 +$292,081,135 $151.95 359
2019 Q1 71,059,216 $8,477,596,090 +$290,725,751 $119.19 359
2018 Q4 68,661,818 $7,492,575,765 +$726,945,004 $109.13 325
2018 Q3 61,212,693 $9,884,755,828 +$245,516,894 $161.51 336
2018 Q2 59,953,943 $7,924,528,334 +$548,877,233 $132.18 311
2018 Q1 56,761,587 $4,203,831,314 +$181,642,965 $74.09 265
2017 Q4 55,206,092 $3,072,290,058 +$54,898,638 $55.64 246
2017 Q3 53,730,465 $2,441,631,878 +$525,830,388 $45.36 229
2017 Q2 42,713,217 $1,439,533,207 +$80,813,352 $33.71 186
2017 Q1 40,738,464 $1,205,704,254 +$221,363,966 $29.60 177
2016 Q4 39,367,759 $1,079,914,087 -$175,937,880 $27.43 175
2016 Q3 42,406,897 $2,603,203,193 +$578,983,777 $61.41 183
2016 Q2 34,630,592 $660,414,393 -$14,436,681 $19.07 142
2016 Q1 35,134,647 $685,755,808 +$88,658,017 $19.52 129
2015 Q4 28,532,796 $1,100,883,608 +$34,445,813 $38.58 146
2015 Q3 27,764,899 $891,509,724 +$36,642,722 $32.11 145
2015 Q2 26,667,019 $811,458,439 +$87,268,791 $30.43 127
2015 Q1 24,203,223 $321,208,632 -$7,502,400 $13.28 111
2014 Q4 24,718,769 $357,295,111 -$43,901,247 $14.47 118
2014 Q3 25,967,938 $547,925,873 -$18,480,997 $21.10 121
2014 Q2 26,655,127 $794,069,375 +$1,202,234 $29.79 126
2014 Q1 26,596,410 $639,243,096 -$12,446,044 $24.03 114